You are here

HEMOSONICS

Company Information
Address
400 Preston Avenue Suite 250
CHARLOTTESVILLE, VA 22903-4585
United States


http://www.hemosonics.com

Information

UEI: PFFKCTPB2NX2

# of Employees: 6


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

    Amount: $499,998.00

    HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...

    SBIRPhase II2017Department of Defense Defense Health Agency
  2. A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

    Amount: $999,727.00

    HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...

    SBIRPhase II2015Department of Defense Defense Health Agency
  3. Development of a POC device to guide efficient use of blood products

    Amount: $1,999,325.00

    DESCRIPTION provided by applicant The Problem The inability of blood to coagulate properly represents a major source of preventable morbidity mortality and unnecessary costs For example over ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  4. A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

    Amount: $149,968.00

    HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...

    SBIRPhase I2014Department of Defense Defense Health Agency
  5. Assessment of Hypercoagulability in Cancer Patients Using Sonorheometry

    Amount: $202,931.00

    DESCRIPTION (provided by applicant): The Problem: Venous thromboembolism (VTE), which encompasses the diseases of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and life-threateni ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  6. Development of a microfluidic device for the assessment of hemostatic function

    Amount: $224,845.00

    DESCRIPTION (provided by applicant): The monitoring and management of the hemostatic balance in neonatal and pediatric patients remains challenging. Although several conditions/procedures are known to ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  7. Development of a point of care diagnostic to guide efficient usage of blood produ

    Amount: $2,241,062.00

    DESCRIPTION (provided by applicant): The Problem: Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience excessive bleeding, which requires ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  8. Development of a diagnostic instrument to manage hemostasis in chronic liver dise

    Amount: $1,512,209.00

    DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  9. Miniature, Portable, Device to Detect and Monitor Coagulopathy

    Amount: $69,992.00

    Trauma is a leading cause of both military and civilian mortality, accounting for roughly 10% of all deaths worldwide. Coagulopathy (disturbance of the physiologic balance between bleeding and clottin ...

    STTRPhase I2010Department of Defense Navy
  10. Development of a diagnostic instrument to manage hemostasis in chronic liver dise

    Amount: $317,884.00

    DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government